Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) EBT Margin (2016 - 2026)

Apyx Medical filings provide 15 years of EBT Margin readings, the most recent being 5.98% for Q4 2025.

  • On a quarterly basis, EBT Margin rose 4342.0% to 5.98% in Q4 2025 year-over-year; TTM through Dec 2025 was 20.5%, a 3305.0% increase, with the full-year FY2025 number at 20.5%, up 3305.0% from a year prior.
  • EBT Margin hit 5.98% in Q4 2025 for Apyx Medical, up from 14.58% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 5.98% in Q4 2025 to a low of 73.57% in Q1 2024.
  • Median EBT Margin over the past 5 years was 45.31% (2022), compared with a mean of 41.11%.
  • Biggest five-year swings in EBT Margin: skyrocketed 10876bps in 2021 and later crashed -4678bps in 2024.
  • Apyx Medical's EBT Margin stood at 11.15% in 2021, then crashed by -321bps to 46.9% in 2022, then crashed by -39bps to 65.05% in 2023, then rose by 24bps to 49.4% in 2024, then soared by 88bps to 5.98% in 2025.
  • The last three reported values for EBT Margin were 5.98% (Q4 2025), 14.58% (Q3 2025), and 32.44% (Q2 2025) per Business Quant data.